AU2003246592A1 - Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases - Google Patents

Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases

Info

Publication number
AU2003246592A1
AU2003246592A1 AU2003246592A AU2003246592A AU2003246592A1 AU 2003246592 A1 AU2003246592 A1 AU 2003246592A1 AU 2003246592 A AU2003246592 A AU 2003246592A AU 2003246592 A AU2003246592 A AU 2003246592A AU 2003246592 A1 AU2003246592 A1 AU 2003246592A1
Authority
AU
Australia
Prior art keywords
tumour
diagnosis
treatment
diseases
marker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003246592A
Inventor
Marie-Laure Fogeron
Udo Kellner
Hermann Lage
Stephanie Lamer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EUROPROTEOME AG
Original Assignee
EUROPROTEOME AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EUROPROTEOME AG filed Critical EUROPROTEOME AG
Publication of AU2003246592A1 publication Critical patent/AU2003246592A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/24—Extraction; Separation; Purification by electrochemical means
    • C07K1/26—Electrophoresis
    • C07K1/28—Isoelectric focusing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2003246592A 2002-06-26 2003-06-26 Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases Abandoned AU2003246592A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10229386.4 2002-06-26
DE10229386 2002-06-26
PCT/EP2003/006748 WO2004003564A2 (en) 2002-06-26 2003-06-26 Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases

Publications (1)

Publication Number Publication Date
AU2003246592A1 true AU2003246592A1 (en) 2004-01-19

Family

ID=29796039

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003246592A Abandoned AU2003246592A1 (en) 2002-06-26 2003-06-26 Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases

Country Status (2)

Country Link
AU (1) AU2003246592A1 (en)
WO (1) WO2004003564A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2809302T3 (en) 2004-01-22 2021-03-03 Univ Miami Coenzyme Q10 formulations to treat solid tumors by intravenous administration
EP2136787B1 (en) 2007-03-22 2019-08-21 Berg LLC Topical formulations having enhanced bioavailability
AU2009233785B2 (en) 2008-04-11 2015-08-20 Berg Llc Methods and use of inducing apoptosis in cancer cells
JP5628807B2 (en) * 2008-08-18 2014-11-19 ソウル ナショナル ユニバーシティー インダストリー ファウンデーション Method for regulating cancer metastasis or cancer cell migration by regulating intracellular levels of lysyl tRNA synthetase
KR20180056816A (en) 2009-05-11 2018-05-29 베르그 엘엘씨 Methods for treatment of disease using an epimetabolic shifter (coenzyme q10)
AU2011224207B2 (en) 2010-03-12 2015-11-19 Berg Llc Intravenous formulations of Coenzyme Q10 (CoQ10) and methods of use thereof
US20120269867A1 (en) 2011-04-04 2012-10-25 Jimenez Joaquin J Methods of treating central nervous system tumors
PE20140628A1 (en) 2011-06-17 2014-05-30 Berg Llc INHALABLE PHARMACEUTICAL COMPOSITIONS
SG11201508272YA (en) 2013-04-08 2015-11-27 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
SG10201907816RA (en) 2013-09-04 2019-09-27 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme q10

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1358349A2 (en) * 2000-06-05 2003-11-05 Avalon Pharmaceuticals Cancer gene determination and therapeutic screening using signature gene sets

Also Published As

Publication number Publication date
WO2004003564A2 (en) 2004-01-08
WO2004003564A3 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
WO2004030615A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004016225A8 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1571968A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004045516A9 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1572091A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004060270A8 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1571968A4 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2003291992A1 (en) Phenylethanolamine derivatives for the treatment of respiratory diseases
WO2003057160A8 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1572091A4 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1553912A4 (en) Compositions and methods for the diagnosis and treatment of tumor
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
AU2002226690A1 (en) Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases
WO2005003154A8 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2003246592A1 (en) Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases
AU2003237792A1 (en) Compositions and methods for the diagnosis and treatment of tumor
TWI347845B (en) Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
AU2003245927A1 (en) Target genes for the diagnosis and treatment of cancer
AU2002364501A1 (en) Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
AU2003303217A1 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
AU2003230849A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2003250912A1 (en) Agents and methods for diagnosis and therapy of cancer and cancer risk assessment
AU2003245858A1 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
WO2005052191A8 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2003274649A1 (en) Diagnostic markers for therapeutic treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase